A new name is entering America’s growing list of public health worries: Chagas disease. Long confined to Latin America, this parasitic infection has quietly crossed the border and is now establishing itself in the United States—particularly in California, Texas, Arizona, Louisiana, and Florida.
The culprit is the triatomine insect, better known as the “kissing bug.” It doesn’t spread the parasite with its bite, but with something far less dignified: its feces. When the bug feeds on a sleeping victim, it often leaves droppings on the skin or mucous membranes.
Rub an eye, scratch a bite, or accidentally ingest the contaminated material, and the parasite T. cruzi can enter the body. From there, the infection may remain silent for years—or lead to devastating consequences.
In its early “acute” stage, Chagas disease may mimic a flu: fever, rash, fatigue, swollen lymph nodes. A swollen eyelid, called Romaña’s sign, can also appear. But the real danger lies in the chronic stage, where 20 to 30 percent of patients develop serious, sometimes fatal complications—heart failure, arrhythmias, digestive blockages, or neurological issues.
According to researchers cited in the CDC’s Emerging Infectious Diseases journal, human cases have already been confirmed in eight states, leading them to recommend Chagas be recognized as endemic to the U.S. In plain language: this isn’t just an imported disease anymore. It’s here to stay.
The scope of the problem remains uncertain. Estimates suggest around 300,000 people in the U.S. are living with Chagas disease, most infected years ago in Latin America. But new locally acquired cases are being documented, and experts believe this is only the “tip of the iceberg.” The disease is notoriously underdiagnosed—clinicians often don’t think to test for it, and patients in rural areas struggle to find providers who understand it.
Treatment exists. Two antiparasitic drugs—Benznidazole and Lampit (nifurtimox)—can kill the parasite, especially if used early. But there is no vaccine, and public awareness is minimal.
The implications are clear: Chagas disease is no longer just a “neglected tropical disease.” It is now a domestic threat, quietly establishing itself in communities unprepared for it. The cases from California are a warning signal, not a curiosity.
Prevention measures sound simple—seal up doors and windows, remove woodpiles and rodent nests near homes, spray pesticides at entry points—but they require vigilance. And until doctors, policymakers, and the public acknowledge that Chagas has joined America’s endemic roster, this silent killer will continue to spread unnoticed.
